OPTIBIOTIX HEALTH PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.75 GBX | 0.00% |
|
-1.39% | -33.64% |
| Mar. 25 | OptiBiotix Health raises GBP1.4 million to invest in "driving sales" | AN |
| Mar. 25 | OptiBiotix Health Raises GBP1.4 Million via Share Placing, Subscription | MT |
Valuation
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 51.17 | 77.1 | 56.39 | 51.01 | 40.45 | 12.08 |
| Enterprise Value (EV) 1 | 49.92 | 75.77 | 56.66 | 50.91 | 39.26 | 11.03 |
| P/E ratio | 29.7 x | -39 x | -28.7 x | 9.56 x | 7.02 x | 4.77 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 268 x | 150 x | 82 x | 33.5 x | 18.3 x | 26.4 x |
| EV / Revenue | 261 x | 147 x | 82.4 x | 33.4 x | 17.7 x | 24.1 x |
| EV / EBITDA | -24.9 x | -55.8 x | -34.8 x | -59 x | -36.5 x | -4.87 x |
| EV / FCF | -42.5 x | -59.8 x | - | -49.9 x | -29.1 x | -14.3 x |
| FCF Yield | -2.35% | -1.67% | - | -2% | -3.44% | -7% |
| Price to Book | 7.26 x | 11 x | 10.9 x | 4.32 x | 2.23 x | 1.11 x |
| Nbr of stocks (in thousands) | 79,332 | 84,724 | 85,441 | 87,941 | 87,941 | 91,191 |
| Reference price 2 | 0.6450 | 0.9100 | 0.6600 | 0.5800 | 0.4600 | 0.1325 |
| Announcement Date | 5/23/18 | 4/29/19 | 5/28/20 | 7/9/21 | 6/27/22 | 6/23/23 |
1GBP in Million2GBP
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.1911 | 0.5143 | 0.6876 | 1.523 | 2.213 | 0.457 |
| EBITDA 1 | -2.007 | -1.357 | -1.628 | -0.8635 | -1.077 | -2.265 |
| EBIT 1 | -2.127 | -1.499 | -1.829 | -1.111 | -1.365 | -2.489 |
| Operating Margin | -1,113.08% | -291.45% | -265.97% | -72.96% | -61.7% | -544.64% |
| Earnings before Tax (EBT) 1 | 1.689 | -1.947 | -2.069 | 5.71 | 6.177 | 2.441 |
| Net income 1 | 1.907 | -1.919 | -1.954 | 5.802 | 6.261 | 2.587 |
| Net margin | 998.28% | -373.19% | -284.24% | 380.89% | 282.93% | 566.08% |
| EPS 2 | 0.0217 | -0.0233 | -0.0230 | 0.0607 | 0.0655 | 0.0278 |
| Free Cash Flow 1 | -1.174 | -1.267 | - | -1.021 | -1.351 | -0.7716 |
| FCF margin | -614.37% | -246.34% | - | -67% | -61.05% | -168.85% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 5/23/18 | 4/29/19 | 5/28/20 | 7/9/21 | 6/27/22 | 6/23/23 |
1GBP in Million2GBP
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | 0.27 | - | - | - |
| Net Cash position 1 | 1.25 | 1.32 | - | 0.09 | 1.19 | 1.05 |
| Leverage (Debt/EBITDA) | - | - | -0.1666 x | - | - | - |
| Free Cash Flow 1 | -1.17 | -1.27 | - | -1.02 | -1.35 | -0.77 |
| ROE (net income / shareholders' equity) | 31.8% | -26.8% | - | 68.9% | 41.7% | 17.8% |
| ROA (Net income/ Total Assets) | -19.9% | -11.9% | - | -6.78% | -5.04% | -9.82% |
| Assets 1 | -9.566 | 16.08 | - | -85.6 | -124.2 | -26.35 |
| Book Value Per Share 2 | 0.0900 | 0.0800 | 0.0600 | 0.1300 | 0.2100 | 0.1200 |
| Cash Flow per Share 2 | 0.0200 | 0.0200 | 0.0100 | 0.0100 | 0.0200 | 0.0100 |
| Capex 1 | 0 | 0 | - | - | - | - |
| Capex / Sales | 0.94% | 0.57% | - | - | - | - |
| Announcement Date | 5/23/18 | 4/29/19 | 5/28/20 | 7/9/21 | 6/27/22 | 6/23/23 |
1GBP in Million2GBP
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -33.64% | 21.65M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- OPTI Stock
- Financials OptiBiotix Health Plc
